WebDec 24, 2024 · A drug-eluting stent with rhombic-shaped drug reservoirs is proposed, aimed at providing long-term drug delivery and enhanced fatigue life. Unique rhombic-shaped reservoirs or channels on the stent struts can increase the total drug capacity and improve the stress distribution for longer fatigue life, without compromising other important clinical … WebOct 10, 2008 · Boston Scientific will present its latest innovations at booth 814 on Level 2 of the Exhibition Hall, including the TAXUS (R) Express2 (TM) Atom (TM) Paclitaxel-Eluting Coronary Stent System, which recently became the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter.
Paclitaxel Eluting Coronary Stent System Boston Scientific Bioz
WebFor healthcare professionals; For patients and caregivers; About Boston Scientific; Search; Menu WebFeb 22, 2012 · Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients /PRNewswire/ -- Boston Scientific Corporation's (NYSE: BSX) ION™... restoration selling guns ohio
Boston Scientific to end Renuvia bioresorbable coronary stent program
WebJul 31, 2024 · Boston Scientific to end Renuvia bioresorbable coronary stent program July 31, 2024 By Fink Densford Boston Scientific (NYSE: BSX) is looking to terminate its Renuvia bioresorbable... WebFeb 1, 2010 · The disputes involved several coronary stent products including Cordis's Cypher stent and Boston Scientific's Liberte, Taxus Liberte and Taxus Express stents. WebOct 15, 2008 · OLYMPIA is designed to analyze real-world clinical outcomes data for Boston Scientific's second-generation TAXUS (R) Liberte (R) Paclitaxel-Eluting Coronary Stent System in the treatment of patients with coronary artery disease. restoration service blanchester oh